Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026)
Regeneron Pharmaceuticals' quarterly Exchange Rate Effect came in at -$900000.0 in Q1 2026, down 250.0% year-on-year from $600000.0 in Q1 2025, and down 200.0% quarter-over-quarter from -$300000.0 in Q4 2025.
Regeneron Pharmaceuticals has reported Exchange Rate Effect for 4 years, with the latest figure at -$900000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 250.0% year-over-year to -$900000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (down 400.0% YoY), and the FY2025 full-year result was $300000.0, up 142.86% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$900000.0, down from -$300000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $800000.0 in Q3 2024, with the low at -$900000.0 in Q1 2026.
- Average Exchange Rate Effect over 4 years is -$141666.7, with a median of -$300000.0 recorded in 2024.
- Peak annual rise in Exchange Rate Effect reached 500.0% in 2024, while the deepest fall reached 450.0% in 2024.
- Tracing REGN's Exchange Rate Effect over 4 years: stood at $200000.0 in 2023, then slumped by 450.0% to -$700000.0 in 2024, then soared by 57.14% to -$300000.0 in 2025, then slumped by 200.0% to -$900000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$900000.0 (Q1 2026), -$300000.0 (Q4 2025), and -$400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -900,000.00 |
| Mar 31, 2026 | -900,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | -200,000.00 |
| Sep 30, 2023 | -200,000.00 |
| Jun 30, 2023 | -400,000.00 |
| Jun 30, 2023 | -400,000.00 |